Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.

Autor: Rubenstein, Robyn N., Kim, Minji, Plotsker, Ethan L., Chu, Jacqueline J., Bell, Tajah, McGriff, De'von, Allen Jr, Robert, Dayan, Joseph H., Stern, Carrie S., Coriddi, Michelle, Disa, Joseph J., Mehrara, Babak J., Matros, Evan, Nelson, Jonas A.
Zdroj: Annals of Surgical Oncology: An Oncology Journal for Surgeons; Apr2024, Vol. 31 Issue 4, p2766-2776, 11p
Abstrakt: Background: Prepectoral implant placement for postmastectomy breast reconstruction has increased in recent years. Benefits of prepectoral reconstruction may include lack of animation deformities and reduced postoperative pain, but its complication profile is currently unclear. This study aimed to examine the complication profile of prepectoral tissue expanders (TEs) to determine factors associated with TE loss. Methods: A retrospective review was performed to identify all patients who underwent immediate prepectoral TE reconstruction from January 2018 to June 2021. The decision to use the prepectoral technique was based on mastectomy skin quality and patient comorbidities. Patient demographics, comorbidities, and operative details were evaluated. Outcomes of interest included TE loss, seroma, hematoma, infection/cellulitis, mastectomy skin flap necrosis requiring revision, and TE exposure. Logistic regression analysis was performed to identify factors associated with TE loss. Results: The study identified 1225 TEs. The most frequent complications were seroma (8.7%, n = 106), infection/cellulitis (8.2%, n = 101), and TE loss (4.2%, n = 51). Factors associated with TE loss in the univariate analysis included ethnicity, history of smoking, body mass index, mastectomy weight, and neoadjuvant chemotherapy. In the multivariate regression analysis, only mastectomy weight had a positive association with TE loss (odds ratio, 1.001; p = 0.016). Conclusion: Prepectoral two-stage breast reconstruction can be performed safely with an acceptable early complication profile. The study data suggest that increasing mastectomy weight is the most significant factor associated with TE loss. Further research examining the quality of the soft tissue envelope and assessing patient-reported outcomes would prove beneficial. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index